Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
letter
. 1961 Dec 9;85(24):1309–1311.

The Biochemistry of Mental Disease

A Hoffer, H Osmond
PMCID: PMC1848623  PMID: 13908086

Full text

PDF
1309

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARBER B. Resistance by scientists to scientific discovery. Science. 1961 Sep 1;134(3479):596–602. doi: 10.1126/science.134.3479.596. [DOI] [PubMed] [Google Scholar]
  2. BENJAMIN J. D. Some considerations in biological research in schizophrenia. Psychosom Med. 1958 Nov-Dec;20(6):427–445. doi: 10.1097/00006842-195811000-00001. [DOI] [PubMed] [Google Scholar]
  3. BULLOUGH W. S. Stress and epidermal mitotic activity. I. The effects of the adrenal hormones. J Endocrinol. 1952 Jul;8(3):265–274. doi: 10.1677/joe.0.0080265. [DOI] [PubMed] [Google Scholar]
  4. Blaschko H., Schlossmann H. The inactivation of adrenaline by phenolases. J Physiol. 1940 Mar 14;98(1):130–140. doi: 10.1113/jphysiol.1940.sp003838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. FISCHER P., DE LANDTSHEER L. Métabolisme de l'adrénochrome et du trihydroxyméthylindole chez le lapin. Experientia. 1950 Aug 15;6(8):305–306. doi: 10.1007/BF02170909. [DOI] [PubMed] [Google Scholar]
  6. FISCHER P., LECOMTE J. Métabolisme de l'adrénochrome, de ses produits de réduction et du trihydroxy-N-méthylindol chez le lapin, le chat et le chien. Bull Soc Chim Biol (Paris) 1951;33(5-6):569–600. [PubMed] [Google Scholar]
  7. FOLEY J. M., BAXTER D. On the nature of pigment granules in the cells of the locus coeruleus and substantia nigra. J Neuropathol Exp Neurol. 1958 Oct;17(4):586–598. doi: 10.1097/00005072-195810000-00005. [DOI] [PubMed] [Google Scholar]
  8. GOLDENBERG M., ARANOW H., Jr, SMITH A. A., FABER M. Pheochromocytoma and essential hypertensive vascular disease. AMA Arch Intern Med. 1950 Dec;86(6):823–836. doi: 10.1001/archinte.1950.00230180028003. [DOI] [PubMed] [Google Scholar]
  9. GREEN S., MAZUR A., SHORR E. Mechanism of the catalytic oxidation of adrenaline by ferritin. J Biol Chem. 1956 May;220(1):237–255. [PubMed] [Google Scholar]
  10. GREWAL R. S. The pharmacological actions of 6-methyladrenaline. Br J Pharmacol Chemother. 1952 Jun;7(2):338–348. doi: 10.1111/j.1476-5381.1952.tb01331.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Green D. E., Richter D. Adrenaline and adrenochrome. Biochem J. 1937 Apr;31(4):596–616. doi: 10.1042/bj0310596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. HARLEY-MASON J., LAIRD A. H., SMYTHIES J. R. The metabolism of mescalin in the human; delayed clinical reactions to mescalin. Confin Neurol. 1958;18(2-4):152–155. doi: 10.1159/000105047. [DOI] [PubMed] [Google Scholar]
  13. HOFFER A., KENYON M. Conversion of adrenaline to adrenolutin in human blood serum. AMA Arch Neurol Psychiatry. 1957 Apr;77(4):437–438. doi: 10.1001/archneurpsyc.1957.02330340113017. [DOI] [PubMed] [Google Scholar]
  14. HOFFER A., OSMOND H. Double blind clinical trials. J Neuropsychiatr. 1961 Jun;2:221–227. [PubMed] [Google Scholar]
  15. HOFFER A., OSMOND H., SMYTHIES J. Schizophrenia; a new approach. II. Result of a year's research. J Ment Sci. 1954 Jan;100(418):29–45. doi: 10.1192/bjp.100.418.29. [DOI] [PubMed] [Google Scholar]
  16. KAUFMANN H., KOCH E. Recherches sur l'élimination urinaire des dérivés d'oxydation des catecholamines. Presse Med. 1959 Jun 6;67(28):1141–1144. [PubMed] [Google Scholar]
  17. KETY S. S. Biochemical theories of schizophrenia. II. Science. 1959 Jun 12;129(3363):1590–1596. doi: 10.1126/science.129.3363.1590. [DOI] [PubMed] [Google Scholar]
  18. LANGEMANN H., KOELLE G. B. Production in vitro of melanin-like pigmentation by cells of the intestinal mucosa. Experientia. 1958 Aug 15;14(8):303–306. doi: 10.1007/BF02167015. [DOI] [PubMed] [Google Scholar]
  19. LECOMTE J., FISCHER P. Sensibilisation par l'adrénochrome et ses dérivés de réduction, des effets de l'adrénaline et de l'excitation sympathique (avec une discussion sur la nature des médiateurs libérés au niveau de la membrane nictitante du chat). Arch Int Physiol. 1951 Feb;58(4):424–440. doi: 10.3109/13813455109144974. [DOI] [PubMed] [Google Scholar]
  20. MASLOVA A. F. Poliarograficheskii metod opredeleniia adrenalina, noradrenalina i veshchestv s nekotorymi svoistvami produktov okisleniia adrenalina. Biokhimiia. 1959 Mar-Apr;24(2):181–186. [PubMed] [Google Scholar]
  21. ROSTON S. The effects of coenzyme A upon the oxidation of epinephrine and norepinephrine. J Biol Chem. 1960 Nov;235:3315–3316. [PubMed] [Google Scholar]
  22. SCHWARZ B. E., WAKIM K. G., BICKFORD R. G., LICHTENHELD F. R. Behavioral and electroencephalographic effects of hallucinogenic drugs; changes in cats on intraventricular injection. AMA Arch Neurol Psychiatry. 1956 Jan;75(1):83–90. doi: 10.1001/archneurpsyc.1956.02330190099012. [DOI] [PubMed] [Google Scholar]
  23. SMYTHIES J. R. Recent advances in the biochemistry of psychosis. Lancet. 1960 Jun 11;1(7137):1287–1289. doi: 10.1016/s0140-6736(60)92265-0. [DOI] [PubMed] [Google Scholar]
  24. SULKOWITCH H., ALTSCHULE M. D. Urinary "epinephrines" in patients with mental and emotional disorders. AMA Arch Gen Psychiatry. 1959 Jul;1:108–115. doi: 10.1001/archpsyc.1959.03590010124014. [DOI] [PubMed] [Google Scholar]
  25. SULKOWITCH H., PERRIN G. M., ALTSCHULE M. D. Excretion of urinary epinephrines in psychiatric disorders. Proc Soc Exp Biol Med. 1957 Jun;95(2):245–247. doi: 10.3181/00379727-95-23181. [DOI] [PubMed] [Google Scholar]
  26. TAKAHASHI Y., AKABANE Y. Brain hexokinase activity. Investigation of brain tissue from rats receiving methamphetamine hydrochloride (Methedrine) and from schizophrenics. Arch Gen Psychiatry. 1960 Dec;3:674–681. doi: 10.1001/archpsyc.1960.01710060106015. [DOI] [PubMed] [Google Scholar]
  27. TAUBMANN G., JANTZ H. Untersuchung über die dem Adrenochrom zugeschriebenen psychotoxischen Wirkungen. Nervenarzt. 1957 Nov 20;28(11):485–488. [PubMed] [Google Scholar]
  28. VEECH R. L., ALTSCHULE M. D., SULKOWITCH H., HOLLIDAY P. D. The urinary lead-acetate-extractable substances in schizophrenia. Arch Gen Psychiatry. 1960 Dec;3:642–645. doi: 10.1001/archpsyc.1960.01710060074010. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES